Author name: Leonardo Arias

El desarrollo de nuevos medicamentos es un proceso largo, costoso y con una elevada tasa de fracaso: cerca del 90% de los candidatos a fármacos no superan el desarrollo clínico. Una de las principales causas es la cardiotoxicidad, los efectos adversos que algunos fármacos pueden …

In the aftermath of the breach, the dental and vision benefits administrator said it notified affected individuals in July and bolstered its security controls.

The proposed “RAPID” pathway could help some new medical devices get national Medicare coverage within months of FDA authorization.

Buying Varex will increase Teledyne’s exposure to the healthcare market. Teledyne said the companies’ imaging technologies complement each other with minimal overlap.

Las webs y aplicaciones que trabajan con tiempo real dependen exclusivamente de su inmediatez, y en pocos ámbitos ese tipo de plataformas se ve tan exigido como en las apps de resultados deportivos en vivo, donde millones de usuarios convergen simultáneamente en momentos crítico …

The Senate referred the former Ralph de la Torre, Steward Health Care’s former CEO, for possible prosecution nearly two years ago after he defied a congressional subpoena. Now, two Senators are asking for an update.

Shifting more procedure costs to hospitals is unlikely to pressure prices for orthopedic implants, CEOs said. 

ITM Isotope Technologies plans on resubmitting its advanced cancer radiopharma therapy to the FDA after addressing the agency’s concerns.

Insilico Medicine CEO Alex Zhavoronkov’s mad dash across the BIO International Convention in June attracted plenty of eyes. But the executive would prefer industry watchers gawk at the billions of dollars’ worth of deals his company has struck.

Despite earlier claims of improvement at the fill-finish plant, the FDA has classified the facility as Official Action Indicated based on inspection findings.